Terminated
Diagnosis and Treatment of Patients With Cystic Fibrosis
Led by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Updated on 2026-02-04
79
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis.
CONDITIONS
Official Title
Diagnosis and Treatment of Patients With Cystic Fibrosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- INCLUSION CRITERIA
- Patients with known or suspected CF and family members of patients with CF.
- >=4 years of age
EXCLUSION CRITERIA
-Concomitant medical, psychiatric or other problems which might complicate interpretation of studies of CF, or for which we are unable to provide adequate care.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Status Unknown
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here